0001104659-23-068343.txt : 20230606
0001104659-23-068343.hdr.sgml : 20230606
20230606080657
ACCESSION NUMBER: 0001104659-23-068343
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230602
FILED AS OF DATE: 20230606
DATE AS OF CHANGE: 20230606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KISHBAUCH MICHAEL D
CENTRAL INDEX KEY: 0001076979
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 23994928
MAIL ADDRESS:
STREET 1: 18 CHERRYVILLE RD
CITY: FLEMINGTON
STATE: NJ
ZIP: 08822
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Astria Therapeutics, Inc.
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 1400
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 1400
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20090127
4
1
tm2317752-9_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-06-02
0
0001454789
Astria Therapeutics, Inc.
ATXS
0001076979
KISHBAUCH MICHAEL D
C/O ASTRIA THERAPEUTICS, INC.
75 STATE STREET, SUITE 1400
BOSTON
MA
02109
1
0
0
0
0
Stock Option (Right to Buy)
11.35
2023-06-02
4
A
0
14100
0
A
2033-06-01
Common Stock
14100
14100
D
This option was granted on June 2, 2023 and will vest in its entirety on the one-year anniversary of the grant date, subject to the director's continued service.
/s/ Ben Harshbarger, as attorney-in-fact for Michael Kishbauch
2023-06-06